1. Home
  2. BKSY vs TSHA Comparison

BKSY vs TSHA Comparison

Compare BKSY & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$21.70

Market Cap

839.0M

Sector

Technology

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.02

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
TSHA
Founded
2013
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
839.0M
1.7B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
BKSY
TSHA
Price
$21.70
$5.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$28.50
$11.63
AVG Volume (30 Days)
813.8K
2.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
21.72
5.56
EPS
N/A
N/A
Revenue
N/A
$9,773,000.00
Revenue This Year
$27.03
N/A
Revenue Next Year
$29.21
$1,152.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.28
52 Week Low
$12.41
$2.72
52 Week High
$52.88
$7.30

Technical Indicators

Market Signals
Indicator
BKSY
TSHA
Relative Strength Index (RSI) 42.40 33.36
Support Level $20.06 $4.37
Resistance Level $24.35 $5.07
Average True Range (ATR) 1.35 0.25
MACD 0.11 -0.04
Stochastic Oscillator 40.63 10.85

Price Performance

Historical Comparison
BKSY
TSHA

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: